Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic abnormalities in angioimmunoblastic lymphadenopathy.

G Pizzolo1, F Vinante, C Agostini

  • 1Cattedra di Ematologia, Verona University, Italy.

Cancer
|November 15, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Family History and Solar Insolation in Bipolar I Disorder.

Acta psychiatrica Scandinavica·2026
Same author

Dissecting heterogeneity in cortical thickness abnormalities in major depressive disorder: a large-scale ENIGMA MDD normative modelling study.

bioRxiv : the preprint server for biology·2025
Same author

Understanding, predicting, and treating depression in pregnancy to improve mothers' and offspring's mental health outcomes: The HappyMums study.

Brain, behavior, & immunity - health·2025
Same author

The use of MSCs in steroid-refractory acute GvHD in Europe: a survey from the EBMT cellular therapy & immunobiology working party.

Bone marrow transplantation·2025
Same author

Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia.

Blood cell therapy·2024
Same author

Delineation of gastrointestinal tumors biopsies using a fluorescence lifetime imaging optical fiber probe.

Journal of biophotonics·2024

Angioimmunoblastic lymphadenopathy (AILD) involves T-cell defects, including reduced T-cells and altered CD4/CD8 ratios. While sharing features with acquired immune deficiency syndrome (AIDS), AILD patients showed no evidence of HTLV-III infection.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Angioimmunoblastic lymphadenopathy (AILD) is a distinct lymphoproliferative disorder.
  • T-cell defects are a suspected but not fully characterized feature of AILD.

Purpose of the Study:

  • To investigate the nature and extent of T-cell abnormalities in patients with AILD.
  • To compare the immunologic profile of AILD with acquired immune deficiency syndrome (AIDS).

Main Methods:

  • Phenotypic, serologic, and functional analyses of T-cell subsets using monoclonal antibodies.
  • In vitro functional assays including mitogen response and helper/suppressor function assessment.
  • Screening for Human T-lymphotropic virus type III (HTLV-III) infection.

Related Experiment Videos

Main Results:

  • Patients exhibited a reduced absolute number of circulating T-cells.
  • An inverted CD4/CD8 ratio was observed in peripheral blood and lymph nodes.
  • High percentages of activated T-cells (CD8+/HLA-DR+) and defective in vitro T-cell responses were noted.
  • AILD patients showed minimal helper and enhanced suppressor T-cell functions in vitro.
  • No evidence of HTLV-III infection was found in the studied AILD cohort.

Conclusions:

  • AILD is characterized by significant and consistent T-cell immune dysfunctions.
  • These T-cell defects, while sharing some similarities with AIDS, are distinct.
  • AILD pathogenesis does not appear to be linked to HTLV-III infection in this patient group.